Bio3 Research S.r.l – Product Pipeline Review – 2012

Introduction

Global Market Direct’s pharmaceuticals report, “Bio3 Research S.r.l - Product Pipeline Review - 2012” provides data on the Bio3 Research S.r.l’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Bio3 Research S.r.l’s corporate website, SEC filings, investor presentations and featured press releases, both from Bio3 Research S.r.l and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Bio3 Research S.r.l - Brief Bio3 Research S.r.l overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Bio3 Research S.r.l human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Bio3 Research S.r.l with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Bio3 Research S.r.l’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Highlights

Reasons to buy

- Evaluate Bio3 Research S.r.l’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Bio3 Research S.r.l in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Bio3 Research S.r.l’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Bio3 Research S.r.l.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Bio3 Research S.r.l and identify potential opportunities in those areas.